Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bard and Tyco keep on talking:

This article was originally published in Clinica

Executive Summary

Bard has reiterated that it is still in discussions with Tyco International over their proposed merger in the light of Tyco's plans to split into four separate businesses (see Clinica No 993, p 15). The conglomerate is also in the news because of questions over its accounting practices. In particular, The Wall Street Journal reported that Tyco had spent $8 billion over the past three years on more than 700 acquisitions that were not made public. Tyco was cleared after an investigation into its accounting practices by the US Securities and Exchange Commission two years ago.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064588

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel